Health IQ
Evidence-based clinical protocols engineered for your unique biological baseline.
Metabolic Baseline Assessor
Enter your clinical metrics below to instantly calculate your BMI, determine your metabolic severity category, and reveal your exact eligibility for our advanced medical protocols.
06 Clinical Programmes
Choose Your Protocol
Essential Protocol
The clinical foundation for sustainable metabolic change.
Premium Protocol
A complete clinical team dedicated entirely to your transformation.
Clinical Education
The science behind GLP-1 and metabolic health
Weight loss is not a willpower problem. It is a hormonal and metabolic one.
Here is the science behind why.
What is GLP-1?
GLP-1 (Glucagon-Like Peptide-1) is a natural hormone produced in your gut after eating. It sends a powerful signal to your brain that you are full. It also slows gastric emptying, suppresses glucagon (a hormone that raises blood sugar), and stimulates insulin release.
In people with obesity, this satiety signal is often dysfunctional. The brain does not receive it properly. GLP-1 receptor agonists like Mounjaro (Tirzepatide) and Ozempic (Semaglutide) are synthetic versions of this hormone, amplified to restore the signal and correct the underlying metabolic dysfunction.
Obesity is not a failure of willpower.
For decades, obesity was wrongly framed as a personal failing. Modern science has conclusively proven this to be false. Obesity is a complex, chronic, neurobiological disease driven by genetics, gut hormones, inflammation, and environmental factors that are largely outside conscious control.
When you lose weight, your body actively fights back, dropping leptin, raising ghrelin, and slowing your metabolism. This is not weakness. It is your body's survival biology working against you. GLP-1 medications work directly on these biological pathways to restore balance.
Understanding obesity severity
| Category | BMI Range | Health Risks | GLP-1 Eligible |
|---|---|---|---|
| Normal Weight | 18.5 to 24.9 | Low | No |
| Overweight | 25.0 to 29.9 | Elevated risk of type 2 diabetes and hypertension | With conditions |
| Obesity Class I | 30.0 to 34.9 | High cardiovascular and metabolic risk | Yes |
| Obesity Class II | 35.0 to 39.9 | Severe risk of sleep apnea, joint disease, and depression | Yes |
| Obesity Class III | 40.0 and above | Critical risk of multi-organ complications | Yes (Priority) |
How GLP-1 treatment works
Metabolic Assessment
Your journey begins with a comprehensive metabolic baseline including BMI, waist to hip ratio, blood pressure, fasting glucose, HbA1c, and a full lipid panel. We understand your metabolic profile completely before any intervention begins.
Physician Consultation
Our licensed clinicians review your assessment and determine the right GLP-1 protocol for you, Mounjaro or Ozempic, starting at the lowest therapeutic dose to allow your body to adjust comfortably.
Ongoing Clinical Monitoring
Week by week tracking of weight, measurements, blood pressure, and blood glucose. Your dose is titrated based on your clinical response, and any side effects are managed proactively throughout the entire programme.
Common side effects and how we manage them
The most common side effect, particularly in the first two weeks. We manage this by starting at the lowest possible dose, encouraging smaller and slower meals, and advising against high-fat or heavily spiced foods during the adjustment period.
A frequent occurrence due to slowed gut motility. We recommend increasing water intake, adding dietary fibre, and light daily movement. Your clinical team can suggest a stool softener if required.
Less common but possible, especially following a dose increase. It is usually self-resolving within a few days. Staying well hydrated and avoiding trigger foods helps considerably.
Caused by delayed gastric emptying and typically resolves within four to six weeks as your body adjusts to the medication and your digestive rhythm settles.
This is the intended therapeutic effect. Your clinical team monitors your nutritional intake throughout to ensure you consistently meet your protein and micronutrient targets.
Some patients experience mild fatigue in the first one to two weeks. This generally resolves on its own and frequently reverses into improved, sustained energy levels as the programme progresses.
Ready to begin your metabolic reset?
Complete your free metabolic baseline assessment and our clinical team will review your eligibility within 24 hours.